CEL-SCI CorpAdd to My Watchlist

CVM:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 0.46
    Last
  • 0.02  -3.92%
    Today's Change
  • 0.48
    Previous Close
  • Today
     
    0.36
    1.23
    52 Week Low - High
8:04 pm ET 2/5/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding130 million
Market Cap$60 million
Return on Equity ttm--
Last DividendCVM:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.434
EPS: Year Est. 9/16 ttm-0.290
 
EPS: Quarterly Actual 9/15 -0.12
EPS: Quarterly Est. 12/15 --
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate12.50
Company Description
CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer.
Revenue$657,377
Net Income$-35 million
Total Assets$15 million
Employees44
Web Sitewww.cel-sci.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!